Diabetic nephropathy and pregnancy.
Knowledge of the pathogenic mechanisms of diabetic nephropathy (by which hyperglycemia, hyperfiltration, and hypertension cause the gradual development of microproteinuria, mesangial expansion, and eventual glomerular closure) provides the basis for effective treatment. Intensified glycemic control and antihypertensive therapy that is safe for the fetus are crucial for success during pregnancy. Considered outcome measures include perinatal survival, size at birth, child development, and long-term maternal renal function.
Kitzmiller
J L
JL
Division of Maternal-Fetal Medicine, Good Samaritan Health System, San Jose, California, USA.
Combs
C A
CA
D000959:Antihypertensive Agents / Q000627:therapeutic use; D001724:Birth Weight; D001786:Blood Glucose / Q000032:analysis; D002657:Child Development; D003928:Diabetic Nephropathies / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D005260:Female; D005333:Fetus; D006801:Humans; D006943:Hyperglycemia / Q000150:complications; D006973:Hypertension / Q000150:complications; D007231:Infant, Newborn; D007668:Kidney / Q000502:physiology; D011247:Pregnancy; D011256:Pregnancy Outcome; D011254:Pregnancy in Diabetics / Q000503:physiopathology / Q000628:therapy*; D011507:Proteinuria / Q000209:etiology
D000959:Antihypertensive Agents; D001786:Blood Glucose